Sign In
Buy TRCK
$0.640
+0 (+0%)
At Close: Jun 03, 2026
Dino Polska: Mixed Q1 Results, But Long Term Growth Is On Track
01:05am, Saturday, 21'st Jun 2025
I maintain my buy rating on Dino Polska, as the company's accelerated store openings and reinvestment support long-term growth despite short-term margin pressure. Dino's unique rural market focus, hig
Despite Today's News, the Semiconductor Index Is Still on Track for $5700
02:51pm, Friday, 13'th Jun 2025
Even a pullback to $4925+/-100 can still allow for a rally to $5700.
Amazon Is on Track to Hit a Critical Level: Watch Out
10:21am, Wednesday, 11'th Jun 2025
After mostly recovering from a brutal multi-month selloff through April, shares of Amazon.com Inc. NASDAQ: AMZN now find themselves at one of those make-or-break moments that could define the next fe
ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod RHO data show efgartigimod achieved sustained reduction in auto
Bitcoin on Track to Hit New All-Time High: 3 Stocks in Focus
09:46am, Tuesday, 10'th Jun 2025
Crypto momentum returns as Bitcoin tops $110K, boosting outlooks for PYPL, V, and CME heading into 2025.
X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA
08:00am, Tuesday, 10'th Jun 2025
BOSTON, June 10, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the U.S. Food
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DV
Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies
09:27am, Wednesday, 04'th Jun 2025
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ: DV
Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis
07:00am, Tuesday, 03'rd Jun 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Receives U.S. FDA Fast Track Designation for AMX0114 for the Treatment of Amyotrophic Lateral Sclerosis.
GARP: Growth ETF With A Solid Track Record
05:20pm, Monday, 02'nd Jun 2025
iShares MSCI USA Quality GARP ETF (GARP) holds 135 growth stocks weighted based on value and quality. Although the strategy is multi-factor, growth is preeminent and GARP is overweight in technology.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commerci
Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow
06:30am, Friday, 30'th May 2025
CHICAGO--(BUSINESS WIRE)--Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow.
Want More Money? These 3 High-Yield Dividend Stocks Are on Track to Give You a Raise Every Single Quarter.
11:02am, Thursday, 29'th May 2025
Most top dividend stocks strive to boost their payments at least once a year. However, some companies are even more generous.
Nebius: AI Scaling Right On Track
08:00pm, Tuesday, 27'th May 2025
Nebius Group N.V.'s Q1 results and ARR surge validate the AI infrastructure growth story, supporting my continued bullish thesis despite recent price appreciation. The company is on track to hit ambit
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
05:30pm, Tuesday, 27'th May 2025
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celi
